0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Medications for Erectile Dysfunction Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-23C18201
Home | Market Reports | Health| Reproductive Health
Global Oral Medications for Erectile Dysfunction Market Research Report 2024
BUY CHAPTERS

Global Oral Medications for Erectile Dysfunction Market Research Report 2024

Code: QYRE-Auto-23C18201
Report
November 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Medications for Erectile Dysfunction Market

The global Oral Medications for Erectile Dysfunction market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Oral medications for erectile dysfunction (ED) are a group of prescription drugs designed to help men achieve and maintain an erection sufficient for sexual activity. The most commonly used oral medications for ED are phosphodiesterase type 5 (PDE5) inhibitors, which include sildenafil, tadalafil, vardenafil, and avanafil.
North American market for Oral Medications for Erectile Dysfunction is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Medications for Erectile Dysfunction is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Medications for Erectile Dysfunction include Pfizer, Eli Lilly, Metuchen Pharmaceuticals, SK Chemicals Life Science, Dong-A Pharmaceutical, Cristália, Hetero, Teva, Aurobindo Pharma, Watson Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Medications for Erectile Dysfunction, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Medications for Erectile Dysfunction.
The Oral Medications for Erectile Dysfunction market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oral Medications for Erectile Dysfunction market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Medications for Erectile Dysfunction manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Medications for Erectile Dysfunction Market Report

Report Metric Details
Report Name Oral Medications for Erectile Dysfunction Market
Segment by Type
  • Sildenafil
  • Tadalafil
  • Vardenafil
  • Avanafil
  • Mirodenafil
  • Udenafil
  • Lodenafil
  • Others
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Eli Lilly, Metuchen Pharmaceuticals, SK Chemicals Life Science, Dong-A Pharmaceutical, Cristália, Hetero, Teva, Aurobindo Pharma, Watson Laboratories, Cipla, Sun Pharma, Lupin, MSN, Zydus, Alkem, Amneal Pharmaceuticals, Dr. Reddy's Laboratories, Chartwell, Eugia Pharma, Qilu Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yangtze River Pharmaceutical, Sichuan Kelun Pharmaceutical, Regenex Pharmaceutical, Haisco Pharmaceutical, Shanghai Huilun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral Medications for Erectile Dysfunction manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral Medications for Erectile Dysfunction in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oral Medications for Erectile Dysfunction Market report?

Ans: The main players in the Oral Medications for Erectile Dysfunction Market are Pfizer, Eli Lilly, Metuchen Pharmaceuticals, SK Chemicals Life Science, Dong-A Pharmaceutical, Cristália, Hetero, Teva, Aurobindo Pharma, Watson Laboratories, Cipla, Sun Pharma, Lupin, MSN, Zydus, Alkem, Amneal Pharmaceuticals, Dr. Reddy's Laboratories, Chartwell, Eugia Pharma, Qilu Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yangtze River Pharmaceutical, Sichuan Kelun Pharmaceutical, Regenex Pharmaceutical, Haisco Pharmaceutical, Shanghai Huilun Pharmaceutical

What are the Application segmentation covered in the Oral Medications for Erectile Dysfunction Market report?

Ans: The Applications covered in the Oral Medications for Erectile Dysfunction Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Oral Medications for Erectile Dysfunction Market report?

Ans: The Types covered in the Oral Medications for Erectile Dysfunction Market report are Sildenafil, Tadalafil, Vardenafil, Avanafil, Mirodenafil, Udenafil, Lodenafil, Others

Recommended Reports

Erectile Dysfunction

Oral Medications

Sexual Health Drugs

1 Oral Medications for Erectile Dysfunction Market Overview
1.1 Product Definition
1.2 Oral Medications for Erectile Dysfunction by Type
1.2.1 Global Oral Medications for Erectile Dysfunction Market Value Comparison by Type (2024-2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Vardenafil
1.2.5 Avanafil
1.2.6 Mirodenafil
1.2.7 Udenafil
1.2.8 Lodenafil
1.2.9 Others
1.3 Oral Medications for Erectile Dysfunction by Application
1.3.1 Global Oral Medications for Erectile Dysfunction Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Oral Medications for Erectile Dysfunction Market Size Estimates and Forecasts
1.4.1 Global Oral Medications for Erectile Dysfunction Revenue 2019-2030
1.4.2 Global Oral Medications for Erectile Dysfunction Sales 2019-2030
1.4.3 Global Oral Medications for Erectile Dysfunction Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Medications for Erectile Dysfunction Market Competition by Manufacturers
2.1 Global Oral Medications for Erectile Dysfunction Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Medications for Erectile Dysfunction Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Medications for Erectile Dysfunction Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Oral Medications for Erectile Dysfunction, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Product Type & Application
2.7 Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Date of Enter into This Industry
2.8 Global Oral Medications for Erectile Dysfunction Market Competitive Situation and Trends
2.8.1 Global Oral Medications for Erectile Dysfunction Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Medications for Erectile Dysfunction Players Market Share by Revenue
2.8.3 Global Oral Medications for Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Medications for Erectile Dysfunction Market Scenario by Region
3.1 Global Oral Medications for Erectile Dysfunction Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Medications for Erectile Dysfunction Sales by Region: 2019-2030
3.2.1 Global Oral Medications for Erectile Dysfunction Sales by Region: 2019-2024
3.2.2 Global Oral Medications for Erectile Dysfunction Sales by Region: 2025-2030
3.3 Global Oral Medications for Erectile Dysfunction Revenue by Region: 2019-2030
3.3.1 Global Oral Medications for Erectile Dysfunction Revenue by Region: 2019-2024
3.3.2 Global Oral Medications for Erectile Dysfunction Revenue by Region: 2025-2030
3.4 North America Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.4.1 North America Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.4.3 North America Oral Medications for Erectile Dysfunction Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.5.1 Europe Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.5.3 Europe Oral Medications for Erectile Dysfunction Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Medications for Erectile Dysfunction Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Medications for Erectile Dysfunction Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Medications for Erectile Dysfunction Sales by Region (2019-2030)
3.6.3 Asia Pacific Oral Medications for Erectile Dysfunction Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.7.1 Latin America Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.7.3 Latin America Oral Medications for Erectile Dysfunction Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Medications for Erectile Dysfunction Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Medications for Erectile Dysfunction Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Medications for Erectile Dysfunction Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Medications for Erectile Dysfunction Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Medications for Erectile Dysfunction Sales by Type (2019-2030)
4.1.1 Global Oral Medications for Erectile Dysfunction Sales by Type (2019-2024)
4.1.2 Global Oral Medications for Erectile Dysfunction Sales by Type (2025-2030)
4.1.3 Global Oral Medications for Erectile Dysfunction Sales Market Share by Type (2019-2030)
4.2 Global Oral Medications for Erectile Dysfunction Revenue by Type (2019-2030)
4.2.1 Global Oral Medications for Erectile Dysfunction Revenue by Type (2019-2024)
4.2.2 Global Oral Medications for Erectile Dysfunction Revenue by Type (2025-2030)
4.2.3 Global Oral Medications for Erectile Dysfunction Revenue Market Share by Type (2019-2030)
4.3 Global Oral Medications for Erectile Dysfunction Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Medications for Erectile Dysfunction Sales by Application (2019-2030)
5.1.1 Global Oral Medications for Erectile Dysfunction Sales by Application (2019-2024)
5.1.2 Global Oral Medications for Erectile Dysfunction Sales by Application (2025-2030)
5.1.3 Global Oral Medications for Erectile Dysfunction Sales Market Share by Application (2019-2030)
5.2 Global Oral Medications for Erectile Dysfunction Revenue by Application (2019-2030)
5.2.1 Global Oral Medications for Erectile Dysfunction Revenue by Application (2019-2024)
5.2.2 Global Oral Medications for Erectile Dysfunction Revenue by Application (2025-2030)
5.2.3 Global Oral Medications for Erectile Dysfunction Revenue Market Share by Application (2019-2030)
5.3 Global Oral Medications for Erectile Dysfunction Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Oral Medications for Erectile Dysfunction Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eli Lilly Oral Medications for Erectile Dysfunction Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Metuchen Pharmaceuticals
6.3.1 Metuchen Pharmaceuticals Company Information
6.3.2 Metuchen Pharmaceuticals Description and Business Overview
6.3.3 Metuchen Pharmaceuticals Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Metuchen Pharmaceuticals Oral Medications for Erectile Dysfunction Product Portfolio
6.3.5 Metuchen Pharmaceuticals Recent Developments/Updates
6.4 SK Chemicals Life Science
6.4.1 SK Chemicals Life Science Company Information
6.4.2 SK Chemicals Life Science Description and Business Overview
6.4.3 SK Chemicals Life Science Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SK Chemicals Life Science Oral Medications for Erectile Dysfunction Product Portfolio
6.4.5 SK Chemicals Life Science Recent Developments/Updates
6.5 Dong-A Pharmaceutical
6.5.1 Dong-A Pharmaceutical Company Information
6.5.2 Dong-A Pharmaceutical Description and Business Overview
6.5.3 Dong-A Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dong-A Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.5.5 Dong-A Pharmaceutical Recent Developments/Updates
6.6 Cristália
6.6.1 Cristália Company Information
6.6.2 Cristália Description and Business Overview
6.6.3 Cristália Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cristália Oral Medications for Erectile Dysfunction Product Portfolio
6.6.5 Cristália Recent Developments/Updates
6.7 Hetero
6.7.1 Hetero Company Information
6.7.2 Hetero Description and Business Overview
6.7.3 Hetero Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Hetero Oral Medications for Erectile Dysfunction Product Portfolio
6.7.5 Hetero Recent Developments/Updates
6.8 Teva
6.8.1 Teva Company Information
6.8.2 Teva Description and Business Overview
6.8.3 Teva Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Oral Medications for Erectile Dysfunction Product Portfolio
6.8.5 Teva Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Company Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aurobindo Pharma Oral Medications for Erectile Dysfunction Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Watson Laboratories
6.10.1 Watson Laboratories Company Information
6.10.2 Watson Laboratories Description and Business Overview
6.10.3 Watson Laboratories Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Watson Laboratories Oral Medications for Erectile Dysfunction Product Portfolio
6.10.5 Watson Laboratories Recent Developments/Updates
6.11 Cipla
6.11.1 Cipla Company Information
6.11.2 Cipla Description and Business Overview
6.11.3 Cipla Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cipla Oral Medications for Erectile Dysfunction Product Portfolio
6.11.5 Cipla Recent Developments/Updates
6.12 Sun Pharma
6.12.1 Sun Pharma Company Information
6.12.2 Sun Pharma Description and Business Overview
6.12.3 Sun Pharma Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sun Pharma Oral Medications for Erectile Dysfunction Product Portfolio
6.12.5 Sun Pharma Recent Developments/Updates
6.13 Lupin
6.13.1 Lupin Company Information
6.13.2 Lupin Description and Business Overview
6.13.3 Lupin Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Oral Medications for Erectile Dysfunction Product Portfolio
6.13.5 Lupin Recent Developments/Updates
6.14 MSN
6.14.1 MSN Company Information
6.14.2 MSN Description and Business Overview
6.14.3 MSN Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.14.4 MSN Oral Medications for Erectile Dysfunction Product Portfolio
6.14.5 MSN Recent Developments/Updates
6.15 Zydus
6.15.1 Zydus Company Information
6.15.2 Zydus Description and Business Overview
6.15.3 Zydus Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zydus Oral Medications for Erectile Dysfunction Product Portfolio
6.15.5 Zydus Recent Developments/Updates
6.16 Alkem
6.16.1 Alkem Company Information
6.16.2 Alkem Description and Business Overview
6.16.3 Alkem Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Alkem Oral Medications for Erectile Dysfunction Product Portfolio
6.16.5 Alkem Recent Developments/Updates
6.17 Amneal Pharmaceuticals
6.17.1 Amneal Pharmaceuticals Company Information
6.17.2 Amneal Pharmaceuticals Description and Business Overview
6.17.3 Amneal Pharmaceuticals Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Amneal Pharmaceuticals Oral Medications for Erectile Dysfunction Product Portfolio
6.17.5 Amneal Pharmaceuticals Recent Developments/Updates
6.18 Dr. Reddy's Laboratories
6.18.1 Dr. Reddy's Laboratories Company Information
6.18.2 Dr. Reddy's Laboratories Description and Business Overview
6.18.3 Dr. Reddy's Laboratories Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Dr. Reddy's Laboratories Oral Medications for Erectile Dysfunction Product Portfolio
6.18.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.19 Chartwell
6.19.1 Chartwell Company Information
6.19.2 Chartwell Description and Business Overview
6.19.3 Chartwell Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Chartwell Oral Medications for Erectile Dysfunction Product Portfolio
6.19.5 Chartwell Recent Developments/Updates
6.20 Eugia Pharma
6.20.1 Eugia Pharma Company Information
6.20.2 Eugia Pharma Description and Business Overview
6.20.3 Eugia Pharma Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Eugia Pharma Oral Medications for Erectile Dysfunction Product Portfolio
6.20.5 Eugia Pharma Recent Developments/Updates
6.21 Qilu Pharmaceutical
6.21.1 Qilu Pharmaceutical Company Information
6.21.2 Qilu Pharmaceutical Description and Business Overview
6.21.3 Qilu Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Qilu Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.21.5 Qilu Pharmaceutical Recent Developments/Updates
6.22 Guangzhou Baiyunshan Pharmaceutical
6.22.1 Guangzhou Baiyunshan Pharmaceutical Company Information
6.22.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
6.22.3 Guangzhou Baiyunshan Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Guangzhou Baiyunshan Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.22.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
6.23 Yangtze River Pharmaceutical
6.23.1 Yangtze River Pharmaceutical Company Information
6.23.2 Yangtze River Pharmaceutical Description and Business Overview
6.23.3 Yangtze River Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Yangtze River Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.23.5 Yangtze River Pharmaceutical Recent Developments/Updates
6.24 Sichuan Kelun Pharmaceutical
6.24.1 Sichuan Kelun Pharmaceutical Company Information
6.24.2 Sichuan Kelun Pharmaceutical Description and Business Overview
6.24.3 Sichuan Kelun Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Sichuan Kelun Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.24.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates
6.25 Regenex Pharmaceutical
6.25.1 Regenex Pharmaceutical Company Information
6.25.2 Regenex Pharmaceutical Description and Business Overview
6.25.3 Regenex Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Regenex Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.25.5 Regenex Pharmaceutical Recent Developments/Updates
6.26 Haisco Pharmaceutical
6.26.1 Haisco Pharmaceutical Company Information
6.26.2 Haisco Pharmaceutical Description and Business Overview
6.26.3 Haisco Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Haisco Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.26.5 Haisco Pharmaceutical Recent Developments/Updates
6.27 Shanghai Huilun Pharmaceutical
6.27.1 Shanghai Huilun Pharmaceutical Company Information
6.27.2 Shanghai Huilun Pharmaceutical Description and Business Overview
6.27.3 Shanghai Huilun Pharmaceutical Oral Medications for Erectile Dysfunction Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Shanghai Huilun Pharmaceutical Oral Medications for Erectile Dysfunction Product Portfolio
6.27.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Medications for Erectile Dysfunction Industry Chain Analysis
7.2 Oral Medications for Erectile Dysfunction Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Medications for Erectile Dysfunction Production Mode & Process
7.4 Oral Medications for Erectile Dysfunction Sales and Marketing
7.4.1 Oral Medications for Erectile Dysfunction Sales Channels
7.4.2 Oral Medications for Erectile Dysfunction Distributors
7.5 Oral Medications for Erectile Dysfunction Customers
8 Oral Medications for Erectile Dysfunction Market Dynamics
8.1 Oral Medications for Erectile Dysfunction Industry Trends
8.2 Oral Medications for Erectile Dysfunction Market Drivers
8.3 Oral Medications for Erectile Dysfunction Market Challenges
8.4 Oral Medications for Erectile Dysfunction Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oral Medications for Erectile Dysfunction Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Oral Medications for Erectile Dysfunction Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Oral Medications for Erectile Dysfunction Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Oral Medications for Erectile Dysfunction Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Oral Medications for Erectile Dysfunction Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Oral Medications for Erectile Dysfunction Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Oral Medications for Erectile Dysfunction Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Oral Medications for Erectile Dysfunction Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Oral Medications for Erectile Dysfunction, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Medications for Erectile Dysfunction, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Medications for Erectile Dysfunction by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Medications for Erectile Dysfunction as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Medications for Erectile Dysfunction Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Oral Medications for Erectile Dysfunction Sales by Region (2019-2024) & (K Units)
 Table 18. Global Oral Medications for Erectile Dysfunction Sales Market Share by Region (2019-2024)
 Table 19. Global Oral Medications for Erectile Dysfunction Sales by Region (2025-2030) & (K Units)
 Table 20. Global Oral Medications for Erectile Dysfunction Sales Market Share by Region (2025-2030)
 Table 21. Global Oral Medications for Erectile Dysfunction Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Oral Medications for Erectile Dysfunction Revenue Market Share by Region (2019-2024)
 Table 23. Global Oral Medications for Erectile Dysfunction Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Oral Medications for Erectile Dysfunction Revenue Market Share by Region (2025-2030)
 Table 25. North America Oral Medications for Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Oral Medications for Erectile Dysfunction Sales by Country (2019-2024) & (K Units)
 Table 27. North America Oral Medications for Erectile Dysfunction Sales by Country (2025-2030) & (K Units)
 Table 28. North America Oral Medications for Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Oral Medications for Erectile Dysfunction Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Oral Medications for Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Oral Medications for Erectile Dysfunction Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Oral Medications for Erectile Dysfunction Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Oral Medications for Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Oral Medications for Erectile Dysfunction Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Oral Medications for Erectile Dysfunction Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Oral Medications for Erectile Dysfunction Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Oral Medications for Erectile Dysfunction Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Oral Medications for Erectile Dysfunction Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Oral Medications for Erectile Dysfunction Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Oral Medications for Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Oral Medications for Erectile Dysfunction Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Oral Medications for Erectile Dysfunction Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Oral Medications for Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Oral Medications for Erectile Dysfunction Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Oral Medications for Erectile Dysfunction Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Oral Medications for Erectile Dysfunction Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Oral Medications for Erectile Dysfunction Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Oral Medications for Erectile Dysfunction Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Oral Medications for Erectile Dysfunction Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Oral Medications for Erectile Dysfunction Sales (K Units) by Type (2019-2024)
 Table 51. Global Oral Medications for Erectile Dysfunction Sales (K Units) by Type (2025-2030)
 Table 52. Global Oral Medications for Erectile Dysfunction Sales Market Share by Type (2019-2024)
 Table 53. Global Oral Medications for Erectile Dysfunction Sales Market Share by Type (2025-2030)
 Table 54. Global Oral Medications for Erectile Dysfunction Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Oral Medications for Erectile Dysfunction Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Oral Medications for Erectile Dysfunction Revenue Market Share by Type (2019-2024)
 Table 57. Global Oral Medications for Erectile Dysfunction Revenue Market Share by Type (2025-2030)
 Table 58. Global Oral Medications for Erectile Dysfunction Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Oral Medications for Erectile Dysfunction Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Oral Medications for Erectile Dysfunction Sales (K Units) by Application (2019-2024)
 Table 61. Global Oral Medications for Erectile Dysfunction Sales (K Units) by Application (2025-2030)
 Table 62. Global Oral Medications for Erectile Dysfunction Sales Market Share by Application (2019-2024)
 Table 63. Global Oral Medications for Erectile Dysfunction Sales Market Share by Application (2025-2030)
 Table 64. Global Oral Medications for Erectile Dysfunction Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Oral Medications for Erectile Dysfunction Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Oral Medications for Erectile Dysfunction Revenue Market Share by Application (2019-2024)
 Table 67. Global Oral Medications for Erectile Dysfunction Revenue Market Share by Application (2025-2030)
 Table 68. Global Oral Medications for Erectile Dysfunction Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Oral Medications for Erectile Dysfunction Price (US$/Unit) by Application (2025-2030)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Pfizer Oral Medications for Erectile Dysfunction Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Eli Lilly Oral Medications for Erectile Dysfunction Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Metuchen Pharmaceuticals Company Information
 Table 81. Metuchen Pharmaceuticals Description and Business Overview
 Table 82. Metuchen Pharmaceuticals Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Metuchen Pharmaceuticals Oral Medications for Erectile Dysfunction Product
 Table 84. Metuchen Pharmaceuticals Recent Developments/Updates
 Table 85. SK Chemicals Life Science Company Information
 Table 86. SK Chemicals Life Science Description and Business Overview
 Table 87. SK Chemicals Life Science Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. SK Chemicals Life Science Oral Medications for Erectile Dysfunction Product
 Table 89. SK Chemicals Life Science Recent Developments/Updates
 Table 90. Dong-A Pharmaceutical Company Information
 Table 91. Dong-A Pharmaceutical Description and Business Overview
 Table 92. Dong-A Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Dong-A Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 94. Dong-A Pharmaceutical Recent Developments/Updates
 Table 95. Cristália Company Information
 Table 96. Cristália Description and Business Overview
 Table 97. Cristália Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Cristália Oral Medications for Erectile Dysfunction Product
 Table 99. Cristália Recent Developments/Updates
 Table 100. Hetero Company Information
 Table 101. Hetero Description and Business Overview
 Table 102. Hetero Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Hetero Oral Medications for Erectile Dysfunction Product
 Table 104. Hetero Recent Developments/Updates
 Table 105. Teva Company Information
 Table 106. Teva Description and Business Overview
 Table 107. Teva Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Teva Oral Medications for Erectile Dysfunction Product
 Table 109. Teva Recent Developments/Updates
 Table 110. Aurobindo Pharma Company Information
 Table 111. Aurobindo Pharma Description and Business Overview
 Table 112. Aurobindo Pharma Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Aurobindo Pharma Oral Medications for Erectile Dysfunction Product
 Table 114. Aurobindo Pharma Recent Developments/Updates
 Table 115. Watson Laboratories Company Information
 Table 116. Watson Laboratories Description and Business Overview
 Table 117. Watson Laboratories Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Watson Laboratories Oral Medications for Erectile Dysfunction Product
 Table 119. Watson Laboratories Recent Developments/Updates
 Table 120. Cipla Company Information
 Table 121. Cipla Description and Business Overview
 Table 122. Cipla Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Cipla Oral Medications for Erectile Dysfunction Product
 Table 124. Cipla Recent Developments/Updates
 Table 125. Sun Pharma Company Information
 Table 126. Sun Pharma Description and Business Overview
 Table 127. Sun Pharma Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Sun Pharma Oral Medications for Erectile Dysfunction Product
 Table 129. Sun Pharma Recent Developments/Updates
 Table 130. Lupin Company Information
 Table 131. Lupin Description and Business Overview
 Table 132. Lupin Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Lupin Oral Medications for Erectile Dysfunction Product
 Table 134. Lupin Recent Developments/Updates
 Table 135. MSN Company Information
 Table 136. MSN Description and Business Overview
 Table 137. MSN Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. MSN Oral Medications for Erectile Dysfunction Product
 Table 139. MSN Recent Developments/Updates
 Table 140. Zydus Company Information
 Table 141. Zydus Description and Business Overview
 Table 142. Zydus Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Zydus Oral Medications for Erectile Dysfunction Product
 Table 144. Zydus Recent Developments/Updates
 Table 145. Alkem Company Information
 Table 146. Alkem Description and Business Overview
 Table 147. Alkem Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Alkem Oral Medications for Erectile Dysfunction Product
 Table 149. Alkem Recent Developments/Updates
 Table 150. Amneal Pharmaceuticals Company Information
 Table 151. Amneal Pharmaceuticals Description and Business Overview
 Table 152. Amneal Pharmaceuticals Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Amneal Pharmaceuticals Oral Medications for Erectile Dysfunction Product
 Table 154. Amneal Pharmaceuticals Recent Developments/Updates
 Table 155. Dr. Reddy's Laboratories Company Information
 Table 156. Dr. Reddy's Laboratories Description and Business Overview
 Table 157. Dr. Reddy's Laboratories Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Dr. Reddy's Laboratories Oral Medications for Erectile Dysfunction Product
 Table 159. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 160. Chartwell Company Information
 Table 161. Chartwell Description and Business Overview
 Table 162. Chartwell Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Chartwell Oral Medications for Erectile Dysfunction Product
 Table 164. Chartwell Recent Developments/Updates
 Table 165. Eugia Pharma Company Information
 Table 166. Eugia Pharma Description and Business Overview
 Table 167. Eugia Pharma Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Eugia Pharma Oral Medications for Erectile Dysfunction Product
 Table 169. Eugia Pharma Recent Developments/Updates
 Table 170. Qilu Pharmaceutical Company Information
 Table 171. Qilu Pharmaceutical Description and Business Overview
 Table 172. Qilu Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Qilu Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 174. Qilu Pharmaceutical Recent Developments/Updates
 Table 175. Guangzhou Baiyunshan Pharmaceutical Company Information
 Table 176. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
 Table 177. Guangzhou Baiyunshan Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. Guangzhou Baiyunshan Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 179. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
 Table 180. Yangtze River Pharmaceutical Company Information
 Table 181. Yangtze River Pharmaceutical Description and Business Overview
 Table 182. Yangtze River Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Yangtze River Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 184. Yangtze River Pharmaceutical Recent Developments/Updates
 Table 185. Sichuan Kelun Pharmaceutical Company Information
 Table 186. Sichuan Kelun Pharmaceutical Description and Business Overview
 Table 187. Sichuan Kelun Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. Sichuan Kelun Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 189. Sichuan Kelun Pharmaceutical Recent Developments/Updates
 Table 190. Regenex Pharmaceutical Company Information
 Table 191. Regenex Pharmaceutical Description and Business Overview
 Table 192. Regenex Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 193. Regenex Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 194. Regenex Pharmaceutical Recent Developments/Updates
 Table 195. Haisco Pharmaceutical Company Information
 Table 196. Haisco Pharmaceutical Description and Business Overview
 Table 197. Haisco Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 198. Haisco Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 199. Haisco Pharmaceutical Recent Developments/Updates
 Table 200. Shanghai Huilun Pharmaceutical Company Information
 Table 201. Shanghai Huilun Pharmaceutical Description and Business Overview
 Table 202. Shanghai Huilun Pharmaceutical Oral Medications for Erectile Dysfunction Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 203. Shanghai Huilun Pharmaceutical Oral Medications for Erectile Dysfunction Product
 Table 204. Shanghai Huilun Pharmaceutical Recent Developments/Updates
 Table 205. Key Raw Materials Lists
 Table 206. Raw Materials Key Suppliers Lists
 Table 207. Oral Medications for Erectile Dysfunction Distributors List
 Table 208. Oral Medications for Erectile Dysfunction Customers List
 Table 209. Oral Medications for Erectile Dysfunction Market Trends
 Table 210. Oral Medications for Erectile Dysfunction Market Drivers
 Table 211. Oral Medications for Erectile Dysfunction Market Challenges
 Table 212. Oral Medications for Erectile Dysfunction Market Restraints
 Table 213. Research Programs/Design for This Report
 Table 214. Key Data Information from Secondary Sources
 Table 215. Key Data Information from Primary Sources
 Table 216. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Medications for Erectile Dysfunction
 Figure 2. Global Oral Medications for Erectile Dysfunction Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Oral Medications for Erectile Dysfunction Market Share by Type: 2023 & 2030
 Figure 4. Sildenafil Product Picture
 Figure 5. Tadalafil Product Picture
 Figure 6. Vardenafil Product Picture
 Figure 7. Avanafil Product Picture
 Figure 8. Mirodenafil Product Picture
 Figure 9. Udenafil Product Picture
 Figure 10. Lodenafil Product Picture
 Figure 11. Others Product Picture
 Figure 12. Global Oral Medications for Erectile Dysfunction Market Value by Application (2024-2030) & (US$ Million)
 Figure 13. Global Oral Medications for Erectile Dysfunction Market Share by Application: 2023 & 2030
 Figure 14. Hospital Pharmacy
 Figure 15. Retail Pharmacy
 Figure 16. Online Pharmacy
 Figure 17. Global Oral Medications for Erectile Dysfunction Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 18. Global Oral Medications for Erectile Dysfunction Market Size (2019-2030) & (US$ Million)
 Figure 19. Global Oral Medications for Erectile Dysfunction Sales (2019-2030) & (K Units)
 Figure 20. Global Oral Medications for Erectile Dysfunction Average Price (US$/Unit) & (2019-2030)
 Figure 21. Oral Medications for Erectile Dysfunction Report Years Considered
 Figure 22. Oral Medications for Erectile Dysfunction Sales Share by Manufacturers in 2023
 Figure 23. Global Oral Medications for Erectile Dysfunction Revenue Share by Manufacturers in 2023
 Figure 24. Global 5 and 10 Largest Oral Medications for Erectile Dysfunction Players: Market Share by Revenue in Oral Medications for Erectile Dysfunction in 2023
 Figure 25. Oral Medications for Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 26. Global Oral Medications for Erectile Dysfunction Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 27. North America Oral Medications for Erectile Dysfunction Sales Market Share by Country (2019-2030)
 Figure 28. North America Oral Medications for Erectile Dysfunction Revenue Market Share by Country (2019-2030)
 Figure 29. United States Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Canada Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Europe Oral Medications for Erectile Dysfunction Sales Market Share by Country (2019-2030)
 Figure 32. Europe Oral Medications for Erectile Dysfunction Revenue Market Share by Country (2019-2030)
 Figure 33. Germany Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. France Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. U.K. Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Italy Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Russia Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Asia Pacific Oral Medications for Erectile Dysfunction Sales Market Share by Region (2019-2030)
 Figure 39. Asia Pacific Oral Medications for Erectile Dysfunction Revenue Market Share by Region (2019-2030)
 Figure 40. China Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Japan Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. South Korea Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. India Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Australia Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. China Taiwan Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Southeast Asia Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Latin America Oral Medications for Erectile Dysfunction Sales Market Share by Country (2019-2030)
 Figure 48. Mexico Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Brazil Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Argentina Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Colombia Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Middle East and Africa Oral Medications for Erectile Dysfunction Sales Market Share by Country (2019-2030)
 Figure 53. Middle East and Africa Oral Medications for Erectile Dysfunction Revenue Market Share by Country (2019-2030)
 Figure 54. Turkey Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Saudi Arabia Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. UAE Oral Medications for Erectile Dysfunction Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 57. Global Sales Market Share of Oral Medications for Erectile Dysfunction by Type (2019-2030)
 Figure 58. Global Revenue Market Share of Oral Medications for Erectile Dysfunction by Type (2019-2030)
 Figure 59. Global Oral Medications for Erectile Dysfunction Price (US$/Unit) by Type (2019-2030)
 Figure 60. Global Sales Market Share of Oral Medications for Erectile Dysfunction by Application (2019-2030)
 Figure 61. Global Revenue Market Share of Oral Medications for Erectile Dysfunction by Application (2019-2030)
 Figure 62. Global Oral Medications for Erectile Dysfunction Price (US$/Unit) by Application (2019-2030)
 Figure 63. Oral Medications for Erectile Dysfunction Value Chain
 Figure 64. Oral Medications for Erectile Dysfunction Production Process
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture